Growth Metrics

Bristol Myers Squibb (BMYMP) Cash from Financing Activities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Cash from Financing Activities for 17 consecutive years, with -$6.0 billion as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 267.17% to -$6.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$10.3 billion through Dec 2025, down 301.83% year-over-year, with the annual reading at -$10.3 billion for FY2025, 301.83% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$6.0 billion at Bristol Myers Squibb, down from -$1.5 billion in the prior quarter.
  • The five-year high for Cash from Financing Activities was $14.6 billion in Q1 2024, with the low at -$7.3 billion in Q1 2021.
  • Average Cash from Financing Activities over 5 years is -$2.4 billion, with a median of -$3.2 billion recorded in 2021.
  • The sharpest move saw Cash from Financing Activities crashed 592.13% in 2021, then soared 580.13% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$4.0 billion in 2021, then increased by 18.17% to -$3.2 billion in 2022, then soared by 129.79% to $967.0 million in 2023, then plummeted by 269.8% to -$1.6 billion in 2024, then tumbled by 267.17% to -$6.0 billion in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$6.0 billion, -$1.5 billion, and -$1.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.